Please try another search
MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada.
Name | Age | Since | Title |
---|---|---|---|
Lyle Oberg | 64 | 2020 | Co-Founder & Executive Chairman of the Board |
John Campbell | 52 | 2020 | President,CEO & Director |
Mark A. Geyer | - | 2021 | Member of Scientific Advisory Board |
Laurie Bakke | - | 2024 | Independent Non Executive Director |
Michael J. Brownstein | - | 2021 | Member of Scientific Advisory Board |
Roslyn Ritchie-Derrien | 61 | 2020 | Independent Director |
Scott Nicoll | - | 2021 | Independent Director |
John Trowsdale | - | 2021 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review